Annual FCF
-$8.56 M
+$12.56 M+59.47%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual free cash flow is -$8.56 million, with the most recent change of +$12.56 million (+59.47%) on December 31, 2023.
- During the last 3 years, AMPE annual FCF has risen by +$6.23 million (+42.10%).
- AMPE annual FCF is now -856300.00% below its all-time high of -$1000.00, reached on December 31, 2006.
Performance
AMPE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.31 M
-$1.75 M-316.04%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly free cash flow is -$2.31 million, with the most recent change of -$1.75 million (-316.04%) on December 31, 2023.
- Over the past year, AMPE quarterly FCF has increased by +$1.99 million (+46.23%).
Performance
AMPE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$8.56 M
+$1.99 M+18.82%
December 31, 2023
Summary
- As of February 8, 2025, AMPE TTM free cash flow is -$8.56 million, with the most recent change of +$1.99 million (+18.82%) on December 31, 2023.
- Over the past year, AMPE TTM FCF has increased by +$12.56 million (+59.47%).
Performance
AMPE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AMPE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.5% | +46.2% | +59.5% |
| 3 y3 years | +42.1% | +20.2% | +42.1% |
| 5 y5 years | +32.6% | +4.0% | +44.4% |
AMPE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.5% | -316.0% | +61.2% | at high | +59.5% |
| 5 y | 5-year | at high | +59.5% | -316.0% | +61.2% | at high | +59.5% |
| alltime | all time | <-9999.0% | +78.3% | <-9999.0% | +81.7% | <-9999.0% | +78.3% |
Ampio Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$8.56 M(-59.5%) | -$2.31 M(+316.0%) | -$8.56 M(-18.8%) |
| Sep 2023 | - | -$555.00 K(-83.7%) | -$10.55 M(-33.8%) |
| Jun 2023 | - | -$3.40 M(+47.7%) | -$15.94 M(-13.8%) |
| Mar 2023 | - | -$2.30 M(-46.4%) | -$18.48 M(-12.5%) |
| Dec 2022 | -$21.13 M(+48.9%) | -$4.29 M(-27.7%) | -$21.13 M(+2.9%) |
| Sep 2022 | - | -$5.94 M(-0.1%) | -$20.54 M(+10.9%) |
| Jun 2022 | - | -$5.95 M(+20.3%) | -$18.52 M(+24.3%) |
| Mar 2022 | - | -$4.94 M(+33.5%) | -$14.90 M(+5.0%) |
| Dec 2021 | -$14.19 M(-4.1%) | -$3.70 M(-5.7%) | -$14.19 M(+6.0%) |
| Sep 2021 | - | -$3.93 M(+68.6%) | -$13.38 M(+9.6%) |
| Jun 2021 | - | -$2.33 M(-44.9%) | -$12.21 M(-15.6%) |
| Mar 2021 | - | -$4.23 M(+46.0%) | -$14.47 M(-2.2%) |
| Dec 2020 | -$14.79 M(-4.0%) | -$2.90 M(+5.1%) | -$14.79 M(-11.2%) |
| Sep 2020 | - | -$2.75 M(-40.0%) | -$16.66 M(-10.6%) |
| Jun 2020 | - | -$4.59 M(+0.8%) | -$18.64 M(+6.4%) |
| Mar 2020 | - | -$4.55 M(-4.3%) | -$17.51 M(+13.7%) |
| Dec 2019 | -$15.40 M(+21.3%) | -$4.76 M(+0.4%) | -$15.40 M(+18.0%) |
| Sep 2019 | - | -$4.74 M(+36.8%) | -$13.05 M(+12.8%) |
| Jun 2019 | - | -$3.46 M(+41.6%) | -$11.57 M(+1.9%) |
| Mar 2019 | - | -$2.44 M(+1.7%) | -$11.36 M(-10.6%) |
| Dec 2018 | -$12.70 M(+10.7%) | -$2.40 M(-26.1%) | -$12.70 M(-1.6%) |
| Sep 2018 | - | -$3.25 M(+0.1%) | -$12.91 M(+0.8%) |
| Jun 2018 | - | -$3.25 M(-14.3%) | -$12.80 M(+1.3%) |
| Mar 2018 | - | -$3.79 M(+45.3%) | -$12.63 M(+10.1%) |
| Dec 2017 | -$11.48 M(-21.5%) | -$2.61 M(-17.0%) | -$11.48 M(+0.3%) |
| Sep 2017 | - | -$3.15 M(+1.9%) | -$11.45 M(+6.0%) |
| Jun 2017 | - | -$3.09 M(+16.9%) | -$10.80 M(-12.7%) |
| Mar 2017 | - | -$2.64 M(+2.2%) | -$12.38 M(-15.4%) |
| Dec 2016 | -$14.63 M(-44.9%) | -$2.58 M(+3.3%) | -$14.63 M(-26.2%) |
| Sep 2016 | - | -$2.50 M(-46.4%) | -$19.81 M(-16.0%) |
| Jun 2016 | - | -$4.66 M(-4.5%) | -$23.59 M(-3.3%) |
| Mar 2016 | - | -$4.88 M(-37.1%) | -$24.39 M(-8.2%) |
| Dec 2015 | -$26.55 M | -$7.77 M(+23.9%) | -$26.55 M(+5.0%) |
| Sep 2015 | - | -$6.27 M(+14.7%) | -$25.30 M(-9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$5.47 M(-22.5%) | -$27.81 M(-20.4%) |
| Mar 2015 | - | -$7.05 M(+8.3%) | -$34.93 M(-11.4%) |
| Dec 2014 | -$39.41 M(+89.7%) | -$6.51 M(-25.9%) | -$39.41 M(+1.2%) |
| Sep 2014 | - | -$8.78 M(-30.2%) | -$38.93 M(+9.5%) |
| Jun 2014 | - | -$12.59 M(+9.2%) | -$35.54 M(+26.5%) |
| Mar 2014 | - | -$11.53 M(+91.1%) | -$28.09 M(+35.2%) |
| Dec 2013 | -$20.77 M(+113.8%) | -$6.03 M(+11.9%) | -$20.77 M(+19.8%) |
| Sep 2013 | - | -$5.39 M(+4.9%) | -$17.34 M(+25.2%) |
| Jun 2013 | - | -$5.14 M(+22.0%) | -$13.85 M(+28.0%) |
| Mar 2013 | - | -$4.21 M(+62.1%) | -$10.82 M(+11.4%) |
| Dec 2012 | -$9.72 M(+5.4%) | -$2.60 M(+36.5%) | -$9.72 M(-13.6%) |
| Sep 2012 | - | -$1.90 M(-9.6%) | -$11.25 M(+3.0%) |
| Jun 2012 | - | -$2.11 M(-32.2%) | -$10.92 M(+3.6%) |
| Mar 2012 | - | -$3.11 M(-24.8%) | -$10.54 M(+14.3%) |
| Dec 2011 | -$9.22 M(+250.7%) | -$4.13 M(+162.4%) | -$9.22 M(+58.2%) |
| Sep 2011 | - | -$1.57 M(-8.5%) | -$5.82 M(+19.3%) |
| Jun 2011 | - | -$1.72 M(-3.6%) | -$4.88 M(+29.9%) |
| Mar 2011 | - | -$1.79 M(+140.9%) | -$3.76 M(+43.0%) |
| Dec 2010 | -$2.63 M(+91.6%) | -$741.60 K(+16.9%) | -$2.63 M(+12.6%) |
| Sep 2010 | - | -$634.20 K(+6.1%) | -$2.34 M(+6.8%) |
| Jun 2010 | - | -$597.60 K(-8.8%) | -$2.19 M(+8.3%) |
| Mar 2010 | - | -$655.00 K(+46.1%) | -$2.02 M(+47.2%) |
| Dec 2009 | -$1.37 M(+3529.4%) | -$448.40 K(-7.8%) | -$1.37 M(+47.4%) |
| Sep 2009 | - | -$486.20 K(+13.1%) | -$930.40 K(+107.6%) |
| Jun 2009 | - | -$429.80 K(+5708.1%) | -$448.10 K(+1408.8%) |
| Mar 2009 | - | -$7400.00(+5.7%) | -$29.70 K(-21.4%) |
| Dec 2008 | -$37.80 K(+106.6%) | -$7000.00(+79.5%) | -$37.80 K(-1.8%) |
| Sep 2008 | - | -$3900.00(-65.8%) | -$38.50 K(+9.1%) |
| Jun 2008 | - | -$11.40 K(-26.5%) | -$35.30 K(+4.4%) |
| Mar 2008 | - | -$15.50 K(+101.3%) | -$33.80 K(+84.7%) |
| Dec 2007 | -$18.30 K(+1730.0%) | -$7700.00(+1000.0%) | -$18.30 K(+72.6%) |
| Sep 2007 | - | -$700.00(-92.9%) | -$10.60 K(+7.1%) |
| Jun 2007 | - | -$9900.00(<-9900.0%) | -$9900.00(<-9900.0%) |
| Mar 2007 | - | $0.00 | $0.00 |
| Dec 2006 | -$1000.00 | - | - |
FAQ
- What is Ampio Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual FCF year-on-year change?
- What is Ampio Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly FCF year-on-year change?
- What is Ampio Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM FCF year-on-year change?
What is Ampio Pharmaceuticals annual free cash flow?
The current annual FCF of AMPE is -$8.56 M
What is the all time high annual FCF for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual free cash flow is -$1000.00
What is Ampio Pharmaceuticals annual FCF year-on-year change?
Over the past year, AMPE annual free cash flow has changed by +$12.56 M (+59.47%)
What is Ampio Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AMPE is -$2.31 M
What is the all time high quarterly FCF for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly free cash flow is $0.00
What is Ampio Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AMPE quarterly free cash flow has changed by +$1.99 M (+46.23%)
What is Ampio Pharmaceuticals TTM free cash flow?
The current TTM FCF of AMPE is -$8.56 M
What is the all time high TTM FCF for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM free cash flow is $0.00
What is Ampio Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AMPE TTM free cash flow has changed by +$12.56 M (+59.47%)